MORGAN STANLEY - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 180 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$14,412,224
+208.3%
523,700
+280.1%
0.00%
Q2 2023$4,675,011
-73.6%
137,784
-72.1%
0.00%
-100.0%
Q1 2023$17,739,760
+95.4%
493,045
+142.1%
0.00%
+100.0%
Q4 2022$9,078,417
+58.7%
203,689
+0.2%
0.00%0.0%
Q3 2022$5,719,000
-56.0%
203,383
-57.8%
0.00%
-50.0%
Q2 2022$12,995,000
-62.6%
482,027
-52.7%
0.00%
-60.0%
Q1 2022$34,708,000
+193.6%
1,019,024
+233.1%
0.01%
+400.0%
Q4 2021$11,821,000
+23.3%
305,933
+72.3%
0.00%0.0%
Q3 2021$9,584,000
+132.7%
177,536
+44.2%
0.00%0.0%
Q2 2021$4,118,000
+809.1%
123,159
+459.7%
0.00%
Q1 2021$453,000
+32.1%
22,005
+12.6%
0.00%
Q4 2020$343,000
+45.3%
19,546
+23.1%
0.00%
Q3 2020$236,000
-21.6%
15,879
-31.4%
0.00%
Q2 2020$301,000
+812.1%
23,142
+18.7%
0.00%
Q1 2020$33,000
-31.2%
19,503
-7.9%
0.00%
Q4 2019$48,000
+140.0%
21,170
+124.1%
0.00%
Q3 2019$20,000
-33.3%
9,446
-15.1%
0.00%
Q2 2019$30,000
+172.7%
11,132
+372.1%
0.00%
Q1 2019$11,0002,3580.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,017,524$20,961,0007.56%
Octagon Capital Advisors LP 561,398$11,565,0004.36%
COMMODORE CAPITAL LP 369,951$7,621,0003.04%
Opaleye Management Inc. 985,000$20,291,0002.98%
VR Adviser, LLC 1,240,610$25,557,0002.77%
TSP Capital Management Group, LLC 359,229$7,400,0002.61%
RTW INVESTMENTS, LP 3,908,947$80,524,0001.26%
Ghost Tree Capital, LLC 250,000$5,150,0001.21%
Tri Locum Partners LP 196,672$4,051,0001.00%
Redmile Group, LLC 3,387,788$69,788,0000.98%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders